Zdrowie i gospodarka · 06/01/2023
FDA Classifies Virtual Reality Device for Pain Relief into Class II Special Controls
The FDA has classified the virtual reality behavioral therapy device for pain relief into Class II special controls, aiming to ensure the device's safety and effectiveness while expanding patients' access to innovative treatments.
Source: Federal Register — Food and Drug AdministrationOpen original release →